Quinazolinones As Parp14 Inhibitors - EP4212515
The patent EP4212515 was granted to Abbvie Biotechnology on Jul 19, 2023. The application was originally filed on Dec 20, 2018 under application number EP22212226A. The patent is currently recorded with a legal status of "Intended To Grant".
EP4212515
- Application Number
- EP22212226A
- Filing Date
- Dec 20, 2018
- Status
- Intended To Grant
- Apr 29, 2025
- Grant Date
- Jul 19, 2023
- External Links
- Slate, Register, Google Patents
Patent Summary
Patent Family
Dossier Documents
The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.
Date
Description
Get instant alerts for new documents